Search Tag: Klebsiella pneumoniae

Executive Health Management


2015 14 Jun

A cutting-edge medical therapy has been developed by researchers at Queen’s University, Belfast that could protect patients against a lethal superbug. The treatment uses a molecule called an inhibitor and prevents the superbug Klebsiella pneumonia from blocking the body’s natural defences. Klebsiella has a mortality rate of 25 to 60 percent...Read more

ICU Management


2017 17 Oct

In an international study in 13 European intensive care units using protocolised surveillance and microbiological analysis, the transmission capacity of bacteria resistant to expanded-spectrum cephalosporins (ESCs) was 3.7 times higher for non-Escherichia coli Enterobacteriaceae (mainly Klebsiella pneumoniae) than for E. coli. The study findings are...Read more